Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Linaclotide versus placebo on colorectal sensorimotor responses in healthy volunteers and constipation-predominant IBS patients
2014-002017-28Phase 4Completed
- Sponsor
- KU Leuven
- Start
- May 2014
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4 trial of linaclotide in irritable bowel syndrome (IBS) (2 arms), sponsored by KU Leuven. Primary endpoints: Objective 1 sensory and motor thresholds in healthy subjects and Objective 2 sensory and motor thresholds in IBS patients. Started May 2014; status: completed.
02
Drugs
linaclotide
03
Conditions
irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on 2014-002017-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-002017-28.